Hangzhou Xu 'an Biotechnology Co., Ltd. focuses on the production and sales of R&D and POCT reagents and instruments. It has a biological raw material technology platform for independent research and development and production of antigens and antibodies, and a mature immune chromatography and dry biochemical diagnosis technology platform. POCT reagents covering eight fields including drug detection, infectious disease detection, chronic disease detection, pregnancy detection, tumor detection, myocardial detection, biochemical detection and allergen detection have been developed.

I. Mission of the Company:

To provide excellent products and services for human health, vision: to become an evergreen tree in the industry, values: customer first, sustainable management; People-oriented, honest and dedicated; Down-to-earth, looking up at the stars; Unity and progress, cooperation and innovation.

II. Scope of business:

Manufacturing and processing: non-medical biological materials and agricultural products, first, second and third class medical devices; Wholesale and retail: Class I, II and III medical devices and pharmaceutical intermediates; Services: biological products technology, computer software technology development, achievement transfer, technical consultation, technical services, import and export of goods (except for projects prohibited by laws and regulations, projects restricted by national laws and regulations can only be operated after obtaining licenses). (Projects subject to approval according to law can only be operated after approval by relevant departments).

Three. Achievements:

At present, it has an R&D production base of10.6 million square meters, and has established an internationally advanced colloidal gold rapid diagnostic reagent production line and POCT integrated instrument. Xu Ansheng is at the leading level in the fields of rapid diagnostic reagent platform, molecular rapid diagnostic platform, development and preparation of immune antibodies, synthesis of small molecular antigens, genetic engineering and so on. More than 9 series 100 products, including pregnancy, drugs, infectious diseases, tumor markers, food safety, biochemical series and instrument reagent integration, have been successfully developed.

Xu An has obtained 60 patents at home and abroad, 35 registered trademarks at home and abroad, and 265,438+0 domestic second-and third-class medical device product registration certificates. It has successively obtained international certifications such as FDA of the United States, CE of the European Union, CMDCAS of Canada and MASAP of five countries, and Xu Ansheng is the first enterprise in China to pass MASAP certification.

At present, Xu Ansheng has high-end microbiology laboratories and biosafety laboratories in the industry, and has established extensive cooperative relations with American universities such as Zhejiang University and Ohio State University. Xu 'an biological products sell well in Europe, America, Asia, Africa, Oceania and other countries and regions.